Loading...

Biomarkers in Heart Disease

ISBN: 978-1-444-30021-5

January 2009

Wiley-Blackwell

256 pages

Description
Biomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine.


The book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around clinical scenarios rather than individual biomarkers.

This book will help the practicing physician decide which biomarkers to measure, when to measure them, how to interpret the results and how to make decisions based on the test result.

About the Author

James de Lemos, MD, Associate Professor of Medicine; J. Fred Schoellkopf, Jr. Chair in Cardiology Research, Director, Coronary Care Unit and Cardiology Fellowship Program, UT Southwestern Medical Center, Dallas, TX, USA.

Features

  • Comprehensive but concise discussion of the role of biomarkers in heart disease

  • Addresses use of biomarkers in current clinical practice, as well as future indications for clinical practice
  • Sections devoted to biomarkers in ischemic heart disease and heart failure, as well as discussions of biomarkers in screening and biomarkers in the future
  • An essential read for anyone interested in the use of biomarkers in clinical practice